INMBINmune Bio, Inc.

$37M

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$428,000

Net Income

-$428,000

EPS (Diluted)

$-0.04

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$375,360

Free Cash Flow

-$375,360

Stock-Based Comp.

$162,634

Balance Sheet

Total Assets

$18M

Total Liabilities

$309,717

Stockholders' Equity

$18M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$428,000	-$84,677	-405.5%
Net Income	-$428,000	-$134,677	-217.8%

INMB Q4 2017 Earnings — INmune Bio, Inc. Revenue & Financial Results | Market Cap Arena